Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 4Unknown 1Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 18Sarcoma 5Other hematologic neoplasm 2Genitourinary 2Endocrine 2Thoracic 1Other solid neoplasm 1Other 1NET 1Lymphoid 1Gastrointestinal 1Dermatologic 1

Conditions

Neuroendocrine Tumors 71Carcinoma, Neuroendocrine 8Gastro-enteropancreatic neuroendocrine tumor 6Carcinoid Tumor 6Neoplasm Metastasis 5Sarcoma 3Paraganglioma 3Pancreatic Neoplasms 3Carcinoma, Hepatocellular 3Adenoma, Islet Cell 3Thyroid Neoplasms 2Stomach Neoplasms 2Neoplasms 2Lung Neoplasms 2Turcot syndrome 1Triple Negative Breast Neoplasms 1Tertiary Lymphoid Structures 1Teratoma 1Small Intestinal Neuroendocrine Tumor 1Small Cell Lung Carcinoma 1Rectal Neuroendocrine Tumor 1Prostatic Neoplasms 1Pheochromocytoma 1Parkinson Disease 1Pancreatic Neuroendocrine Tumors in MEN1 1Osteomalacia 1Neuroendocrine Tumors With Metastasis 1Neuroendocrine Tumors Metastatic to the Liver 1Neuroendocrine Tumor Grade 3 1Neuroblastoma 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Medulloblastoma × NET × Clear all
NCT03734913 2020-07-22

A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors

Guangdong Zhongsheng Pharmaceutical Co., Ltd.

Phase 1 Unknown
65 enrolled
CNSDermatologicEndocrineNETThoracic

Carcinoma, Basal Cell, Glioblastoma, Medulloblastoma, Neuroendocrine Tumors, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡